The 2023 Türkiye-Syria earthquakes: analysis of pediatric victims with crush syndrome and acute kidney Injury.

Autor:	Döven, Serra Sürmeli, Tezol, Özlem, Yeşil, Edanur, Durak, Fatma, Mısırlıoğlu, Merve, Alakaya, Mehmet, Karahan, Feryal, Kıllı, İsa, Akça, Mehtap, Erdoğan, Semra, Can, Mevlüt, Delibaş, Ali
Předmět:	VICTIMS LEUKOCYTE count GOODNESS-of-fit tests GLUCOSE CRUSH syndrome ACADEMIC medical centers T-test (Statistics) DATA analysis CREATININE PHYSIOLOGIC salines PHOSPHORUS HOSPITAL care FISHER exact test LOGISTIC regression analysis HYPERKALEMIA ASPARTATE aminotransferase SODIUM bicarbonate POTASSIUM HEMOGLOBINS ACUTE kidney failure SYMPTOMS RETROSPECTIVE studies MANN Whitney U Test HYPERURICEMIA DESCRIPTIVE statistics LACTATE dehydrogenase HYPOKALEMIA INTRAVENOUS therapy ODDS ratio HYPOCALCEMIA CALCIUM SODIUM STATISTICS ALANINE aminotransferase UREA URIC acid HYPONATREMIA INFLAMMATION LENGTH of stay in hospitals NATURAL disasters BIOMARKERS C-reactive protein MYOGLOBIN ACIDOSIS SERUM albumin DISEASE risk factors CHILDREN
Zdroj:	Pediatric Nephrology; Jul2024, Vol. 39 Issue 7, p2209-2215, 7p
Abstrakt:	Background: On February 6th, 2023, two consecutive earthquakes struck southeastern Türkiye with magnitudes of 7.7 and 7.6, respectively. This study aimed to analyze the clinical and laboratory findings, as well as management of pediatric victims with Crush Syndrome (CS) and Acute Kidney Injury (AKI). Methods: The study included pediatric earthquake victims who were presented to Mersin University Hospital. Clinical and laboratory characteristics of the patients were collected retrospectively. Results: Among 649 patients, Crush injury (CI), CS and AKI was observed in 157, 59, and 17 patients, respectively. White blood cell count (12,870 [IQR: 9910–18700] vs. 10,545 [IQR: 8355–14057] /µL, P < 0.001), C-reactive protein (51.27 [IQR: 14.80–88.78] vs. 4.59 [1.04–18.25] mg/L, P < 0.001) and myoglobin levels (443.00 [IQR: 198.5–1759.35] vs. 17 [11.8–30.43] ng/ml) were higher in patients with CS, while their sodium (IQR: 134 [131–137] vs. 136 [134–138] mEq/L, P < 0.001) levels were lower compared to non-CS patients. An increase in myoglobin levels was identified as an independent risk factor for developing CS (OR = 1.017 [1.006–1.027]). Intravenous fluid replacement was administered to the patients with CS at a dose of 4000 cc/m2/day. Hypokalemia was observed in 51.9% of the CS patients on the third day. All patients with AKI showed improvement and no deaths were reported. Conclusions: Hyponatremia and increase in inflammation markers associated with CS may be observed. An increase in myoglobin levels was identified as a risk factor for CS. Hypokalemia may be seen as a complication of vigorous fluid therapy during hospitalization. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink